Non-cryopreserved stem cells for transplantation in patients with multiple myeloma.

被引：0
|
作者：
Rule, S
McQuillan, A
Pawson, R
Davies, J
Thomas, W
Johnson, S
Joske, D
Erber, W
机构：
[1] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
[2] Musgrave Pk Hosp, Taunton, Somerset, England
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4750
引用
收藏
页码：341B / 341B
页数：1
相关论文
共 50 条
  • [41] Non-myeloablative allogeneic transplantation in patients with relapsed or refractory multiple myeloma.
    Gerull, S
    Hegenbart, U
    Goerner, M
    Benner, A
    Moehler, T
    Goldschmidt, H
    Ho, AD
    BLOOD, 2004, 104 (11) : 755A - 755A
  • [42] Vaccination with dendritic cell myeloma fusions alone or in conjunction with stem cell transplantation for patients with multiple myeloma.
    Avigan, David
    Rosenblatt, Jacalyn
    Vasir, Baldev
    Wu, Zekui
    Bissonnette, Adam
    MacNamara, Claire
    Uhl, Lynne
    Lenahan, Corrine
    Miller, Kenneth
    Joyce, Robin
    Levine, James D.
    Proper, Joanne
    Forino, Patricia
    Dombagoda, Dilani
    Richardson, Paul
    Munshi, Nikhil C.
    Kufe, Donald
    BLOOD, 2006, 108 (11) : 878A - 878A
  • [43] Identification and characterization of cancer stem cells in multiple myeloma.
    Sze, Daniel
    Loh, Yen S.
    Mo, Suilin
    Kaplan, Warren
    Brown, Ross D.
    Ho, Phoebe Joy
    Gibson, John
    Joshua, Douglas E.
    BLOOD, 2006, 108 (11) : 155A - 155A
  • [44] Characterization of mesenchymal stem cells abnormalities in multiple myeloma.
    Bourin, Philippe
    Corre, Jill
    Mahtouk, Karene
    Gadelorge, Melanie
    Laharrague, Patrick
    Klein, Bernard
    Reme, Thierry
    Attal, Michel
    BLOOD, 2006, 108 (11) : 155A - 155A
  • [45] Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma
    Morie A. Gertz
    Martha Q. Lacy
    Eapen K. Jacob
    William J. Hogan
    Bone Marrow Transplantation, 2021, 56 : 978 - 979
  • [46] Autologous peripheral blood stem cell transplantation in Jehovah Witnesses patients with multiple myeloma.
    Kotb, R
    Damaj, G
    Dreyfus, F
    Bouscary, D
    BLOOD, 2000, 96 (11) : 371B - 371B
  • [47] Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma
    Gertz, Morie A.
    Lacy, Martha Q.
    Jacob, Eapen K.
    Hogan, William J.
    BONE MARROW TRANSPLANTATION, 2021, 56 (04) : 978 - 979
  • [48] NON-CRYOPRESERVED PERIPHERAL BLOOD STEM CELL AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE MYELOMA AS A SAFE ALTERNATIVE IN COUNTRIES WITH LOW RESOURCES: A NINE-YEARS OF BICENTRIC EXPERIENCE
    Ahchouch, Siham
    Doghmi, Othman
    Jennane, Selim
    Mahtat, El Mehdi
    Bougar, Sara
    Zafad, Saadia
    El Maaroufi, Hicham
    Doghmi, Kamal
    BONE MARROW TRANSPLANTATION, 2024, 59 : 519 - 519
  • [49] Autologous stem cell transplantation versus no transplant in patients above 70 with multiple myeloma.
    Lemieux, Christopher
    Muffly, Lori S.
    Iberri, David Joseph
    Rezvani, Andrew
    Lowsky, Robert
    Frank, Matthew Joshua
    Craig, Juliana K.
    Liedtke, Michaela
    Negrin, Robert
    Weng, Wen-Kai
    Meyer, Everett
    Johnston, Laura J.
    Shizuru, Judith
    Shiraz, Parveen
    Arai, Sally
    Miklos, David Bernard
    Sidana, Surbhi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Stem cell cryopreservation is not required for single autologous peripheral stem cell transplantation in patients with multiple myeloma.
    Bazarbachi, A
    Fadel, E
    Haidar, J
    Jaafar, H
    Mahfouz, R
    Shmalieh, I
    Jisr, T
    Ibrahim, A
    BLOOD, 1999, 94 (10) : 334B - 334B
12345